Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 403
Selected: 0
NCT IDTitle
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT01683175Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
NCT00815867Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant
NCT00193609Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
NCT00484328Ribavirin, Its Dosing Regime
NCT04661358Fenofibrate for Prevention of DR Worsening
NCT03449914The GOLD Study: G8 in OLDer Patients
NCT05529524Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
NCT05293015NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NCT05050214Obinutuzumab in Primary MN
NCT01674738TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
NCT00459771Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
NCT03275311Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
NCT03301493Genomic Testing and Resulting Medical Decisions
NCT00127036Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
NCT01370772Intensified Rituimab Prephase Before FCR in Untreated B-CLL
NCT00963534Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
NCT01752192Teledi@Log - Tele-rehabilitation of Heart Patients
NCT06663098Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).
NCT06068985Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
NCT035905355th Generation cTnT in ED ACS
NCT03654833Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
NCT02323555Optimize the Requirements and Preparations in Outpatient Chemotherapy
NCT00901524ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV
NCT00189683Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT03721653FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
NCT03046381Tocilizumab in Patients With Schnitzler's Syndrome
NCT03322865Obinutuzumab in Marginal Zone Lymphoma
NCT00976456Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer
NCT05825261Exploring Novel Biomarkers for Emphysema Detection
NCT03272477Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
NCT03691077Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714
NCT05733611RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
NCT02569736Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation
NCT00719264Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
NCT04984811NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
NCT02433522Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab
NCT05017142Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT02060669Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
NCT01652560Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
NCT04939662Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects
NCT02562378T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
NCT02099292Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma
NCT01172392A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
NCT00219739STI571 ProspectIve RandomIzed Trial: SPIRIT
NCT04947605Epidemiological Landscape of Cervical Cancer in Latin America
NCT00457301Using Health-related Quality of Life (HRQL) in Routine Clinical Care
NCT01593332Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
NCT05825625NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing